GLIVEC

In 2006 Novartis had sued Indian Government for not granting patent to its anti cancer drug Imatinib selling under brand name ” Glivec“. It also challenged the constitutional validity of section 3 d of Indian Patent Act 1970 which says new forms including esters, ethers, acids or other derivatives of known substance are not [...]